Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

著者: Karim Fizazi, Howard I. Scher, Arturo Molina, Christopher J. Logothetis, Kim N., Robert J. Jones, John Staffurth, Scott North, Nicholas J. Vogelzang, Fred Saad, Paul N. Mainwaring, Stephen Harland, Oscar B. Goodman, Cora N. Sternberg, Jin Hui Li, Thian Kheoh, Christopher M. Haqq, Johann S. de Bono - The Lancet 2012 被引用: 1,387